Researchers point to a host-directed Covid-19 antiviral that could be combined with existing pandemic treatments
As Covid-19 mutates once again, leading to the newly halted use of GSK/Vir’s monoclonal antibody treatment, researchers are looking for ways to attack SARS-CoV-2 through …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
